Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 5:10:49-56.
doi: 10.1016/j.jbo.2018.01.003. eCollection 2018 Mar.

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

Affiliations

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study

Roger von Moos et al. J Bone Oncol. .

Abstract

Background: Bone metastases and lytic lesions due to multiple myeloma are common in advanced cancer and can lead to debilitating complications (skeletal-related events [SREs]), including requirement for radiation to bone. Despite the high frequency of radiation to bone in patients with metastatic bone disease, our knowledge of associated healthcare resource utilization (HRU) is limited.

Methods: This retrospective study estimated HRU following radiation to bone in Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden and Switzerland. Eligible patients were ≥ 20 years old, had bone metastases secondary to breast, lung or prostate cancer, or bone lesions associated with multiple myeloma, and had received radiation to bone between 1 July 2004 and 1 July 2009. HRU data were extracted from hospital patient charts from 3.5 months before the index SRE (radiation to bone preceded by a SRE-free period of ≥ 6.5 months) until 3 months after the last SRE that the patient experienced during the study period.

Results: In total, 482 patients were included. The number of inpatient stays increased from baseline by a mean of 0.52 (standard deviation [SD] 1.17) stays per radiation to bone event and the duration of stays increased by a mean of 7.8 (SD 14.8) days. Outpatient visits increased by a mean of 4.24 (SD 6.57) visits and procedures by a mean of 8.51 (SD 7.46) procedures.

Conclusion: HRU increased following radiation to bone across all countries studied. Agents that prevent severe pain and delay the need for radiation have the potential to reduce the burden imposed on healthcare resources and patients.

Keywords: Bone metastases; Bone pain; Health resource utilization; Radiation to bone; Skeletal-related event.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study design and data collection for patients with (a) one SRE and (b) multiple SREs. aTo ensure lack of carry-over of HRU from a previous SRE that occurred before the 3.5-month pre-SRE period, a clean window of an additional 3 months without an SRE was required. bFor multiple SREs, the post-index SRE observational period was extended to 3 months following the last observed SRE. To ensure that any HRU used to diagnose the SRE is included in the HRU burden for the SRE, there is a 2-week diagnosis period immediately before the SRE. Estimate of HRU associated with SRE = (post-SRE period + diagnosis period) − baseline period. Data were adjusted to allow for the different lengths of the baseline and post-baseline periods. When multiple SREs were observed at the same anatomical site and within a 21-day window, HRU was attributed to the index SRE. When multiple SREs were observed at the same anatomical site but outside a 21-day window, or multiple SREs were observed at different anatomical sites on the same or different days, the expert panel attributed HRU to the respective SRE. HRU, healthcare resource utilization; SRE, skeletal-related event.
Fig. 2
Fig. 2
Mean change from baseline in (a) the number and (b) the duration of inpatient stays per radiation to bone event. Data are shown as mean (+ standard deviation). N, number of patients enrolled from each country.
Fig. 3
Fig. 3
Mean change from baseline in the number of (a) outpatient visits, (b) procedures and (c) day-care visits per radiation to bone event. Data are shown as mean (+ standard deviation). N, number of patients enrolled from each country.
Fig. 4
Fig. 4
Mean change from baseline in the number of (a) outpatient visits and (b) procedures per radiation to bone event by the most common provider types or procedures. Data are shown as mean (+ standard deviation). N, number of patients enrolled from each country.

Similar articles

References

    1. Coleman R.E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat. Rev. 2001;27(3):165–176. - PubMed
    1. Nilsson S. Radionuclide therapies in prostate cancer: integrating Radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer. Curr. Oncol. Rep. 2016;18(2):14. - PMC - PubMed
    1. von Moos R., Body J.J., Egerdie B., Stopeck A., Brown J.E., Damyanov D., Fallowfield L.J., Marx G., Cleeland C.S., Patrick D.L., Palazzo F.G., Qian Y., Braun A., Chung K. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer. 2013;21(12):3497–3507. - PubMed
    1. WHO, WHO’s Cancer Pain Ladder for Adults. 〈http://www.who.int/cancer/palliative/painladder/en〉. (accessed 26 January 2017).
    1. Ripamonti C.I., Santini D., Maranzano E., Berti M., Roila F., Group E.G.W. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann. Oncol. 2012;23(Suppl. 7) (vii139–54) - PubMed

LinkOut - more resources